Global Financial Private Client, LLC Gilead Sciences, Inc. Transaction History
Global Financial Private Client, LLC
- $239 Billion
- Q2 2024
A detailed history of Global Financial Private Client, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 167 shares of GILD stock, worth $12,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
167
Previous 317
47.32%
Holding current value
$12,675
Previous $23.1 Million
50.4%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
1,876Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$9.16 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.75 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$5.79 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$4.59 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.5 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $95.1B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...